Impaired in vivo reendothelialization capacity of endothelial progenitor cells of patients with type-2 diabetes is restored by PPAR-gamma agonist rosiglitazone: Role of NAD(P)H oxygenase and nitric oxide
2015 ◽
Vol 458
(4)
◽
pp. 869-876
◽
2014 ◽
Vol 64
(16)
◽
pp. C211
2016 ◽
Vol 10
(4)
◽
pp. 205-212
◽